Bildkälla: Stockfoto

Amniotics Q3 2023: Rights Issue Foundation for Lung Transplantation Study - Redeye

Redeye comments on Amniotics' Q3 report, including the rights issue and latest development with the main candidate PulmoStem.

Redeye comments on Amniotics' Q3 report, including the rights issue and latest development with the main candidate PulmoStem.
Börsvärldens nyhetsbrev
ANNONSER